Form 483

Hawaiian Islands Trading Company LLC Form 483, 2019-06-21

FDA issued a Form 483 to Hawaiian Islands Trading Company LLC on 2019-06-21 with 17 public-safe observations.

483· Form 483 issuedFoods & Cosmetics17 observations

Hawaiian Islands Trading Company LLC · Kailua Kona, United States · Issued June 21, 2019

Overview

  • 17 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Jun 2019
21 CFR 111.105(b)

Quality control - supplier qualification

Cited by Kenneth Boehnen

21 Jun 2019
21 CFR 111.110(b)

Quality control operations - tests, examinations

Cited by Kenneth Boehnen

21 Jun 2019
21 CFR 111.140(b)(1)

Records - quality control operations; responsibilities

Cited by Kenneth Boehnen

21 Jun 2019
21 CFR 111.30(c)

Equipment - automated - calibrate, inspect

Cited by Kenneth Boehnen

21 Jun 2019
21 CFR 111.535(b)(1)

Records - returned dietary supplement: written procedures

Cited by Kenneth Boehnen

Inspected site

HIHawaiian Islands Trading Company LLCKailua Kona, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.535(b)(1)Cited across public-safe Form 483 observations3x
21 CFR 111.553Cited across public-safe Form 483 observations3x
21 CFR 111.70(d)Cited across public-safe Form 483 observations3x
21 CFR 111.105(b)Cited across public-safe Form 483 observations2x
21 CFR 111.110(b)Cited across public-safe Form 483 observations2x
21 CFR 111.140(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.30(c)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 17 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere